| Name | (13Z,16Z,19Z)-docosatrienoic acid |
|---|---|
| Synonyms |
13,16,19-Docosatrienoic acid, (13E,16E,19E)-
13Z,16Z,19Z-DOCOSATRIENOIC ACID Cis,cis,cis 13C,16C,19C-DOCOSATRIENOIC ACID CIS-13,16,19-DOCOSATRIENOIC ACID Cis,cis,cis-13,16,19-Docosatrienoic Docosa-13Z,16Z,19Z-trienoic acid,22:3,N-3 (13E,16E,19E)-13,16,19-Docosatrienoic acid 13-cis,16-cis,19-cis-Docosatrienoic acid DOCOSATRIENOIC ACID DOCOSA-13Z,16Z,19Z-TRIENOIC ACID |
| Description | Docosatrienoic acid is a rare ω-3 fatty acid; inhibits LTB4 binding to pig neutrophil membranes with an Ki of 5 μM. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| In Vitro | Docosatrienoic acid inhibits LTB4 binding to pig neutrophil membranes with an Ki of 5 μM[1]. |
| In Vivo | Application of docosatrienic acid dose-dependently decreases the peak K+ current amplitide and accelerates the potassium activation and inactivation kinetics at all rat membrane potentials[2]. |
| References |
| Density | 0.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 459.1±14.0 °C at 760 mmHg |
| Molecular Formula | C22H38O2 |
| Molecular Weight | 334.536 |
| Flash Point | 355.8±15.2 °C |
| Exact Mass | 334.287170 |
| PSA | 37.30000 |
| LogP | 8.63 |
| Vapour Pressure | 0.0±2.4 mmHg at 25°C |
| Index of Refraction | 1.488 |
| Storage condition | 2-8℃ |